Alector (ALEC) Cash & Current Investments (2018 - 2026)
Alector (ALEC) posted quarterly Cash & Current Investments of $206.5 million for Q1 2026, down 41.75% year-over-year from $354.6 million in Q1 2025, and down 19.34% quarter-over-quarter from $256.0 million in Q4 2025.
Alector (ALEC) Cash & Current Investments (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Cash & Current Investments for 9 consecutive years, with $206.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments fell 41.75% year-over-year to $206.5 million; the TTM figure through Mar 2026 stood at $206.5 million (down 41.75% YoY), while the FY2025 annual figure was $256.0 million, down 38.07% from the prior year.
- Cash & Current Investments retreated to $206.5 million in Q1 2026 per ALEC's latest filing, from $256.0 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $868.6 million in Q1 2022 and bottomed at $206.5 million in Q1 2026.
- Historically, Cash & Current Investments has averaged $525.7 million across 5 years, with a median of $548.9 million in 2023.
- Annual changes were most pronounced in 2022 — Cash & Current Investments surged 153.11% — and 2026, when it tumbled 41.75%.
- Alector's Cash & Current Investments stood at $712.9 million in 2022, then dropped by 23.0% to $548.9 million in 2023, then retreated by 24.68% to $413.4 million in 2024, then slumped by 38.07% to $256.0 million in 2025, then slipped by 19.34% to $206.5 million in 2026.
- Business Quant data shows ALEC's Cash & Current Investments at $206.5 million in Q1 2026, $256.0 million in Q4 2025, and $291.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 836.99 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.16 Bn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | 172.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 172.80 Mn |
| Mar 31, 2026 | 206.52 Mn |
| Dec 31, 2025 | 256.02 Mn |
| Sep 30, 2025 | 291.11 Mn |
| Jun 30, 2025 | 307.28 Mn |
| Mar 31, 2025 | 354.55 Mn |
| Dec 31, 2024 | 413.40 Mn |
| Sep 30, 2024 | 457.20 Mn |
| Jun 30, 2024 | 503.33 Mn |
| Mar 31, 2024 | 562.08 Mn |
| Dec 31, 2023 | 548.86 Mn |
| Sep 30, 2023 | 588.86 Mn |
| Jun 30, 2023 | 630.05 Mn |
| Mar 31, 2023 | 669.33 Mn |
| Dec 31, 2022 | 712.85 Mn |
| Sep 30, 2022 | 758.31 Mn |
| Jun 30, 2022 | 808.86 Mn |
| Mar 31, 2022 | 868.57 Mn |
| Dec 31, 2021 | 735.25 Mn |
| Sep 30, 2021 | 777.85 Mn |